AXIN2 and inflammatory bowel disease: Furthermore, recent studies on IBD-associated colorectal cancer (CRC) revealed that negative regulators of Wnt, such as AXIN2 and RFN43, are downregulated in 31 tissue sample of patients with IBD-CRC (49).